logo-loader
NASDAQ:GPRO

Gen-Probe

Receive alerts
Market:
NASDAQ
Market Cap:
$715.12 m
Price
$4.64
Change
1.75%
52 weeks high
7.64
52 weeks low
3.62

In brief

Gen-Probe Incorporated (Gen-Probe) is engaged in the development, manufacture and marketing of nucleic acid tests (NATs) used to diagnose human diseases and screening donated human blood. It also markets a range of products to detect infectious microorganisms, including those causing sexually transmitted diseases (STDs), tuberculosis, strep throat, and other infections. The Company categorizes its products into clinical diagnostic products and blood screening products.